Precision Biosciences (DTIL) Receivables (2018 - 2026)
Precision Biosciences (DTIL) recorded Receivables of $4 million in fiscal Q1 2026 (quarter ended Mar 31, 2026), compared with $4,000 a year earlier.
Powered by 
Analysis
Precision Biosciences (DTIL) Receivables (2018 - 2026) Analysis & Trends
At the end of FY2024 (ended Dec 31, 2024), Precision Biosciences reported Receivables of $229,000, down 74.6% from FY2023.
- Annual Receivables has a five-year compound annual growth rate of -25.0% (FY2019 to FY2024).
- Across earlier fiscal years, Receivables came in at $901,000 in FY2023 (+25.1%), $720,000 in FY2022 (+47.5%), $488,000 in FY2021 (-95.1%) and $10 million in FY2020 (+936.3%).
- The fiscal Q1 2026 figure is the highest quarterly Receivables since fiscal Q2 2022.
- Peak year-over-year performance for Receivables in the last five years was growth of 488.0% in fiscal Q2 2021, against a decline of 99.0% in fiscal Q1 2025 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 23.48 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 18.99 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 13.82 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 12.56 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 9.64 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 15.68 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 10.23 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 5.06 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 12.49 Bn |
| 10 | Precision Biosciences | 179.22 Mn | -169.97 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 4.00 Mn |
| Sep 30, 2025 | 4,000.00 |
| Mar 31, 2025 | 4,000.00 |
| Dec 31, 2024 | 229,000.00 |
| Sep 30, 2024 | 188,000.00 |
| Jun 30, 2024 | 207,000.00 |
| Mar 31, 2024 | 390,000.00 |
| Dec 31, 2023 | 901,000.00 |
| Sep 30, 2023 | 3.51 Mn |
| Jun 30, 2023 | 652,000.00 |
| Mar 31, 2023 | 694,000.00 |
| Dec 31, 2022 | 720,000.00 |
| Sep 30, 2022 | 715,000.00 |
| Jun 30, 2022 | 50.51 Mn |
| Mar 31, 2022 | 488,000.00 |
| Dec 31, 2021 | 488,000.00 |
| Sep 30, 2021 | 488,000.00 |
| Jun 30, 2021 | 488,000.00 |
| Mar 31, 2021 | 19.26 Mn |
| Dec 31, 2020 | 10.00 Mn |
API Access
Precision Biosciences Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=DTIL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "DTIL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=DTIL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();